| 1 | Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Coautor: Meza-Meneses P., Axfors C., Schmitt A.M., Janiaud P., et al. | 2021 | NATURE COMMUNICATIONS | WoS-id: 000641853800001
Scopus-id: 2-s2.0-85104110050
| 141 | 208 |
| 2 | Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (Nature Communications, (2021), 12, 1, (2349), 10.1038/s41467-021-22446-z) | Coautor: Meza-Meneses P., Axfors C., Schmitt A.M., Janiaud P., et al. | 2021 | NATURE COMMUNICATIONS | WoS-id: 000658734400002
Scopus-id: 2-s2.0-85105938543
| 11 | 10 |
| 3 | Candida glabrata antifungal resistance and virulence factors, a perfect pathogenic combination | Coautor: Meza-Meneses P., Frías-De-León M.G., Hernández-Castro R., Conde-Cuevas E., et al. | 2021 | Pharmaceutics | WoS-id: 000717210600001
Scopus-id: 2-s2.0-85115853955
| 9 | 25 |
| 4 | Epidemiology of systemic mycoses in the covid-19 pandemic | Coautor: Meza-Meneses P., Frías-De-León M.G., Pinto-Almazán R., Hernández-Castro R., et al. | 2021 | Journal Of Fungi | Scopus-id: 2-s2.0-85111121488
| 0 | 25 |
| 5 | Infectious complications as a predictor of mortality in patients with non-hodgkin lymphoma receiving rituximab- containing chemotherapy | 1ᵉʳ autor: Meza-Meneses P., Cornejo-Juárez P., Vilar-Compte D., Volkow-Fernández P. | 2019 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000505684200007
Scopus-id: 2-s2.0-85071482425
| 4 | 3 |